Author： Burton MJ Frick KD Bailey RL Bowman RJC
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.3, Iss.2, 2002-02, pp. : 113-120
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Azithromycin treatment for active trachoma increases risk of reinfection
Inpharma, Vol. 1, Iss. 1557, 2006-01 ,pp. :
Access to resources
Recommend
Strategies to Control Trachoma
Drugs, Vol. 69, Iss. 8, 2009-06 ,pp. :
A SAFE trachoma treatment programme in Sudan
Inpharma, Vol. 1, Iss. 1551, 2006-01 ,pp. :
Current Trachoma Treatment Methodologies: Focus on Advancements in Drug Therapy
Drugs, Vol. 62, Iss. 18, 2002-01 ,pp. :
Azithromycin produces long lasting control of C. trachomatis infection
Inpharma, Vol. 1, Iss. 1483, 2005-01 ,pp. :